The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sukhanova S.A.

Omsk State Medical University

Timakova A.Yu.

Omsk State Medical University

Livzan M.A.

Omsk State Medical University

Fedorin M.M.

Omsk State Medical University

Skirdenko Yu.P.

Omsk State Medical University

Gaus O.V.

Omsk State Medical University

Andreev K.A.

Omsk State Medical University

Gorbenko A.V.

Omsk State Medical University

Plinder M.I.

Omsk State Medical University

Adherence to treatment of patients with irritable bowel syndrome: state of the issue

Authors:

Sukhanova S.A., Timakova A.Yu., Livzan M.A., Fedorin M.M., Skirdenko Yu.P., Gaus O.V., Andreev K.A., Gorbenko A.V., Plinder M.I.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2021;24(8): 101‑108

DOI: 10.17116/profmed202124081101

Read: 2104 times

Download PDF (RU)
Contact the author
Table of contents

ADHERENCE TO TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME: STATE OF THE ISSUE
ADHERENCE TO TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME: STATE OF THE ISSUE

To cite this article:

Sukhanova SA, Timakova AYu, Livzan MA, et al. . Adherence to treatment of patients with irritable bowel syndrome: state of the issue. Russian Journal of Preventive Medicine. 2021;24(8):101‑108. (In Russ.)
https://doi.org/10.17116/profmed202124081101

 
 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43
Obje­ctive Moni­toring of Compliance with Compression Treatment in Patients with Chro­nic Venous Disease is Better than Self-Reported Using Patient’s Diary. Journal of Venous Diso­rders. 2025;(2):113-119
Abstract:

Irritable bowel syndrome (IBS) is a common functional bowel disorder that develops mainly in people of working age and significantly reduces the quality of patients’ life. It was found that the chronic recurrent course and the severity of clinical manifestations of IBS dictate the need for constant or periodic intake of a number of drugs and, in some cases, dietary restrictions, which is accompanied by the risk of a significant decrease in adherence to medical recommendations. Currently, a number of methods are known to improve adherence to treatment for IBS. However, the long-term effectiveness of adherence correction methods requires further research. The presented literature review was prepared in order to systematize knowledge about the characteristics of adherence to treatment in patients with IBS. Literature searches were carried out in Embase, PubMed and Google Scholar systems using the keywords: irritable bowel syndrome, adherence, and adherence enhancement techniques.

Keywords:

irritable bowel syndrome
adherence
adherence enhancement techniques

Authors:

Sukhanova S.A.

Omsk State Medical University

Timakova A.Yu.

Omsk State Medical University

Livzan M.A.

Omsk State Medical University

Fedorin M.M.

Omsk State Medical University

Skirdenko Yu.P.

Omsk State Medical University

Gaus O.V.

Omsk State Medical University

Andreev K.A.

Omsk State Medical University

Gorbenko A.V.

Omsk State Medical University

Plinder M.I.

Omsk State Medical University

Received:

23.03.2021

Accepted:

31.03.2021

Close metadata

References:

  1. Sheptulin AA, Vize-Khripunova MA. Review of Rome-IV criteria for the irritable bowel syndrome: are there any basic changes? Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(5):99-103. (In Russ.).
  2. Pogromov AP, Mnatsakanyan MG, Tashchyan OV. The prevalence of irritable bowel syndrome. Klinicheskaya meditsina. 2016;94(11):869-874. (In Russ.). https://doi.org/10.18821/0023-2149-2016-94-11-869-874
  3. Livzan MA, Nikolaev NA, Skirdenko YuP, Fedorin MM, Gorbenko AV, Andreev KA, Andreeva EK, Ivanov AI, Ivakhnenko AT. Nutritional behavior in a student community. Kremlin Medicine Journal. 2019;2:13-16. (In Russ.). https://doi.org/10.26269/tvs8-by34
  4. Zhestkova TV. Quality of Life and Level of Physical Activity In Students with and without Symptoms of Functional Dyspepsia and Irritable Bowel Syndrome Surveyed with Questionnaire “7×7” (7 Symptoms Per 7 Days). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(3): 36-41. (In Russ.). https://doi.org/10.22416/1382-4376-2020-30-3-36-41
  5. Akhmedov VA, Orlov IN, Gaus OV. Modern methods of rehabilitation of patients with irritable bowel syndrome. Therapy. 2017;3(13):49-55. (In Russ.).
  6. Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B. Patients with irritable bowel syndrome- diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol. 2015;21(26):8103-8109. https://doi.org/10.3748/wjg.v21.i26.8103
  7. Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15:35.  https://doi.org/10.1186/s12955-017-0611-2
  8. Schmulson MJ, Drossman DA. What is new in Rome IV. Journal of Neurogastroenterology and Motility. 2017;23(2):151-163.  https://doi.org/10.5056/jnm16214
  9. Pilipenko VI, Morozov SV, Isakov VA. Dietoterapiya sindroma razdrazhennogo kishechnika s problemami zaporov s ispol’zovaniem spetsializirovannogo pishchevogo produkta dieticheskogo lechebnogo pitaniya «kontsentrat kiselya s vitaminami i inulinom "Intenorm"». Russian Journal of Evidence-based Gastroenterology. 2018;7(4):92-106. (In Russ.). https://doi.org/10.17116/dokgastro2018704192
  10. Gaus OV, Livzan MA. Fundamental Basis for the Formation of Abdominal Pain in Patients with Irritable Bowel Syndrom. Effektivnaya farmakoterapiya. 2020;16(15):102-111. (In Russ.). https://doi.org/10.33978/2307-3586-2020-16-15-102-111
  11. Ruchkina IN, Vyaznikova AA, Indeikina LKh, Degterev DA, Parfenov AI. Multidisciplinary treatment of the patient with a severe irritable bowel syndrome. Therapeutic Archive. 2020;92(2):81-84. (In Russ.).
  12. Sheptulina AF, Ivashkin VT. Irritable bowel syn-drome concept from the gut microbiom point of view. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;6(26):120-123. (In Russ.).
  13. Tikhonova TA, Kozlova IV, Fedotov EA. Genetic and psychological prerequisites for development of refractory variant of irritable bowel syndrome. Experimental and Clinical Gastroenterology. 2019;2:68-74. (In Russ.). https://doi.org/10.31146/1682-8658-ecg-162-2-68-74
  14. Morozova MA, Rupchev GE, Alekseev AA, Beniashvili AG, Mayevskaya MV, Poluektova EA, Okhlobystina OZ, Ivashkin VT. Dysphoric spectrum of emotional disorders at irritable bowel syndrome. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(1):12-22. (In Russ.).
  15. Andreev DN, Dicheva DT. Optimizing the treatment of patients with irritable bowel syndrome: focus on increased compliance. Medical Council. 2019;3:118-124. (In Russ.). https://doi.org/10.21518/2079-701X-2019-3-118-124
  16. O’Malley D. Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2016;311(5):934-941.  https://doi.org/10.1152/ajpgi.00272.2016
  17. Bunova SS, Zhernakova NI, Fedorin MM, Skirdenko YuP, Osipova OA. Effective antihypertensive therapy: focus on adherence management. Cardiovascular Therapy and Prevention. 2020;19(5):2663. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2663
  18. Nikolaev NA, Martynov AI, Skirdenko YuP, Anisimov VN, Vasilyeva IA, Vinogradov OI, Lazebnik LB, Poddubnaya IV, Roitman EV, Ershov AV, Ageev FT, Andreev KA, Babicheva LG, Bunova SS, Viktorova IA, Volchegorsky IA, Vorobyev PA, Galyavich AS, Gaus OV, Gomberg VG, Gorbenko AV, Drapkina OM, Zadionchenko VS, Zyryanov SK, Karpov RS, Kobalava ZhD, Kolbasnikov SV, Kondratyeva KO, Konradi AO, Livzan MA, Malyavin AG, Mareev VYu, Medvedeva IV, Mikhailova NB, Moiseev SV, Morozova OL, Napalkov DA, Nedoshivin AO, Nelidova AV, Nechaeva GI, Nikiforov VS, Pisklakov AV, Popov SV, Ptushkin VV, Rebrov AP, Saifutdinov RI, Semiglazova TYu, Sovalkin VI, Sovetkina NV, Terentyev VP, Totchiev GF, Tumyan GS, Tyurin VP, Fedorin MM, Fofanova TV, Shepel RN, Yagoda AV, Yakushin SS. Management of treatment on the basis of adherence. Consensus document — Clinical recommendations. RSMSIM, SSGR, NATH, SEBN, GS RAS, RSH, RSP. Consilium Medicum. 2020;22(5):9-18. (In Russ.).
  19. Naletov AV, Naletov SV, Barinova AS, Vunichenko YuS. The compliance improving is the important step in effective therapy of gastrointestinal tract diseases. Gastroenterologiya Sankt-Peterburga. 2017;3:13-15. (In Russ.).
  20. Kasimova LN, Goryacheva EE. Social and psychological characteristics of patients having gastrointestinal pathology with a various degree of tendencies to therapy. Medical Almanac. 2017;5(50):154-157. (In Russ.).
  21. Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intest Res. 2017;15(4):434-445.  https://doi.org/10.5217/ir.2017.15.4.434
  22. Osipenko MF, Livzan MA, Bikbulatova EA. Patient compliance as one of the factors determining the efficiency of eradication therapy. Therapeutic Archive. 2014;86(2):27-31. (In Russ.).
  23. Buzunova YuM, Belousova EA. Commitment to treating patients with inflammatory bowel disease. Experimental & Clinical Gastroenterology. 2015;5(117):79. (In Russ.).
  24. Alekseeva OP, Kasimova LN, Goryacheva EE. Treatment compliance of patients with gastro-intestinal diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(1):20-28. (In Russ.).
  25. Lovell RM, Ford AC. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis. Am J Gastroenterol. 2012;107(12):1793-1801. https://doi.org/10.1038/ajg.2012.336
  26. Matoshina IV, Fedorin MM, Livzan MA, Mozgovoy SI. Resistance of the Esophageal Mucosa in Patients with GERD: the Dialogue Between Clinician and Pathologist. Effective Pharmacotherapy. 2021;17(4):34-39. (In Russ.).
  27. Corsetti M., Caenepeel P, Fischler B, Janssens J, Tack J. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterology. 2004;99(6):1152-1159.
  28. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(10):1474-1482. https://doi.org/10.1038/ajg.2012.260
  29. Goryacheva EE, Kitaeva II. Structure of anxiety disorders and treatment compliance of patients with functional gastrointestinal pathologies. Nevrologicheskij vestnik. 2015;157(2):72-76. (In Russ.).
  30. Ivashkin VT, Shelygin YuA, Baranskaya EK, Belousova EA, Beniashvili AG, Vasilyev SV, Golovenko AO, Golovenko OV, Grigoryev EG, Kostenko NV, Lapina TL, Loranskaya ID, Lyashenko OS, Maev IV, Poluektova EA, Rumyantsev VG, Timerbulatov VM, Trukhmanov AS, Fomenko OYu, Khalif IL, Chashkova EYu, Sheptulin AA, Shifrin OS, Yanovoy VV. Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(5):76-93. (In Russ.).
  31. El-Salhy M, Hatlebakk JG, Hausken T. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. Nutrients. 2019;11(8):1824. https://doi.org/10.3390/nu11081824
  32. Nanayakkara WS, Skidmore PM, O’Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016;9:131-142.  https://doi.org/10.2147/CEG.S86798
  33. Halmos EP, Gibson PR. Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome. J Gastroenterol Hepatol. 2019;34(7): 1134-1142. https://doi.org/10.1111/jgh.14650
  34. Kostenko MB, Livzan MA. Mekhanizmy razvitiya sindroma razdrazhennogo kishechnika. Sibirskij zhurnal gastrojenterologii i gepatologii. 2000;10:32. (In Russ.).
  35. Gaus OV, Livzan MA, Popello DV. Power management for irritable bowel syndrome. Experimental and Clinical Gastroenterology. 2020;(10):112-122. (In Russ.). https://doi.org/10.31146/1682-8658-ecg-182-10-112-122
  36. Livzan MA. Gastroenterology pain syndrome — therapy algorithm. Medical Council. 2010;3(4):69-71. (In Russ.).
  37. Gaus OV, Livzan MA. Irritable bowel syndrome: what do we know about symptoms today? Consilium Medicum. 2019;21(8):42-48. (In Russ.). https://doi.org/10.26442/20751753.2019.8.190512
  38. Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9(9):940.  https://doi.org/10.3390/nu9090940
  39. Gravina AG, Dallio M, Romeo M, Di Somma A, Cotticelli G, Loguercio C, Federico A. Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation. Nutrients. 2020;12(4):928.  https://doi.org/10.3390/nu12040928
  40. Harvie RM, Chisholm AW, Bisanz JE, Burton JP, Herbison P, Schultz K, Schultz M. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World J Gastroenterol. 2017;23(25): 4632-4643. https://doi.org/10.3748/wjg.v23.i25.4632
  41. Weynants A, Goossens L, Genetello M, De Looze D, Van Winckel M. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome. J Hum Nutr Diet. 2020;33(2):159-169.  https://doi.org/10.1111/jhn.12706
  42. Wong Z, Mok CZ, Majid HA, Mahadeva S. Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome. JGH Open. 2018;2(5):178-181.  https://doi.org/10.1002/jgh3.12069
  43. De Roest RH, Dobbs BR, Chapman BA, Batman B, O’Brien LA, Leeper JA, Hebblethwaite CR, Gearry RB. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract. 2013;67(9):895-903.  https://doi.org/10.1111/ijcp.12128
  44. Mari A, Hosadurg D, Martin L, Zarate-Lopez N, Passananti V, Emmanuel A. Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Eur J Gastroenterol Hepatol. 2019; 31(2):178-182.  https://doi.org/10.1097/MEG.0000000000001317
  45. Chumpitazi BP, Alfaro-Cruz L, Zia JK, Shulman RJ, Heitkemper MM. Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Front Nutr. 2019;6:136.  https://doi.org/10.3389/fnut.2019.00136
  46. Frieling T, Heise J, Krummen B, Hundorf C, Kalde S. Tolerability of FODMAP — reduced diet in irritable bowel syndrome — efficacy, adherence, and body weight course. Z Gastroenterol. 2019;57(6):740-744.  https://doi.org/10.1055/a-0859-7531
  47. Clevers E, Tran M, Van Oudenhove L, Störsrud S, Böhn L, Törnblom H, Simrén M. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome. Nutrition. 2020;73:110719. https://doi.org/10.1016/j.nut.2020.110719
  48. Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Simrén M. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149(6):1399-1407. https://doi.org/10.1053/j.gastro.2015.07.054
  49. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011;24(5):487-495.  https://doi.org/10.1111/j.1365-277X.2011.01162.x
  50. Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm P. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol. 2014;20(43):16215-16226. https://doi.org/10.3748/wjg.v20.i43.16215
  51. Cozma-Petruţ A, Loghin F, Miere D, Dumitraşcu DL. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World J Gastroenterol. 2017;23(21):3771-3783. https://doi.org/10.3748/wjg.v23.i21.3771
  52. Rej A, Sanders DS. Gluten-Free Diet and Its ‘Cousins’ in Irritable Bowel Syndrome. Nutrients. 2018;10(11):1727. https://doi.org/10.3390/nu10111727
  53. Zanwar VG, Pawar SV, Gambhire PA, Jain SS, Surude RG, Shah VB, Contractor QQ, Rathi PM. Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial. Intest Res. 2016;14(4):343-350.  https://doi.org/10.5217/ir.2016.14.4.343
  54. Paduano D, Cingolani A, Tanda E, Usai P. Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life. Nutrients. 2019;11(7):1566. https://doi.org/10.3390/nu11071566
  55. Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M, Sanders DS. Efficacy of a Gluten-Free Diet in Subjects with Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype. Clin Gastroenterol Hepatol. 2016;14(5):696-703.  https://doi.org/10.1016/j.cgh.2015.12.031
  56. Kosyura SD, Livantsova EV, Varaeva YuR, Kopelev AA, Chervyakova YuB, Postnikova SL, Kislyak OA, Starodubova AV. Assessment of the quality of life of patients with irritable bowel syndrome on the background of complex therapy with the inclusion of butyric acid preparations. Experimental and Clinical Gastroenterology. 2019;6:55-61. (In Russ.).
  57. Livzan MA, Osipenko MF. Sindrom perekresta funktsional’nykh zabolevanij pishchevaritel’nogo trakta. RMZh. 2012;20(15):768-770. (In Russ.).
  58. Sherwin LB, Deroche CB, Krisanabud P, Matteson-Kome M, Bechtold M, Ruppar T. Adherence to Short-course Pharmacotherapy in Adults with Irritable Bowel Syndrome. West J Nurs Res. 2020;42(7):524-534.  https://doi.org/10.1177/0193945919872419
  59. Pozuelo M, Panda S, Santiago A, Mendez S, Accarino A, Santos J, Guarner F, Azpiroz F, Manichanh C. Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep. 2015;5:12693. https://doi.org/10.1038/srep12693
  60. Laterza L, Napoli M, Scaldaferri F, Petito V, Colombo S, Gasbarrini A. IDDF2019-ABS-0192 Compliance to probiotic therapy in irritable bowel syndrome in clinical practice: a real-life study. Gut. 2019;68(Suppl 1):A101.
  61. Zia JK, Barney P, Cain KC, Jarrett ME, Heitkemper MM. A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year. Clin Gastroenterol Hepatol. 2016;14(2):212-219.  https://doi.org/10.1016/j.cgh.2015.09.027
  62. Kamat N, Rajan Mallayasamy S, Sharma P, Kamath A, Pai G. Effect of video-assisted patient education on compliance with therapy, quality of life, psychomorbidity, and cost of illness in irritable bowel syndrome. Postgrad Med. 2019;131(1):60-67.  https://doi.org/10.1080/00325481.2019.1549458
  63. Fedorin MM, Gorbenko AV, Andreev KA, Okhotnikova PI, Demko IV, Skirdenko YuP, Livzan MA, Nikolaev NA. Medical background and potential adherence to treatment — solid cross-sectional surprises. The Russian Journal of Preventive Medicine. 2020;23(6):15-21. (In Russ.). https://doi.org/10.17116/profmed20202306115
  64. Nikolaev NA, Martynov AI, Skirdenko YuP, Anisimov VN, Vasilyeva IA, Vinogradov OI, Lazebnik LB, Poddubnaya IV, Roitman EV, Ageev FT, Andreev KA, Babicheva LG, Bunova SS, Viktorova IA, Volchegorsky IA, Galyavich AS, Gaus OV, Gomberg VG, Gorbenko AV, Drapkina OM, Ershov AV, Zyryanov SK, Karpov RS, Kobalava ZhD, Kolbasnikov SV, Kondratyeva KO, Konradi AO, Livzan MA, Malyavin AG, Mareev VYu, Medvedeva IV, Mikhailova NB, Moiseev SV, Morozova OL, Napalkov DA, Nedoshivin AO, Nelidova AV, Nechaeva GI, Nikiforov VS, Pisklakov AV, Popov SV, Ptushkin VV, Rebrov AP, Saifutdinov RI, Semiglazova TYu, Sovalkin VI, Sovetkina NV, Terentyev VP, Totchiev GF, Tumyan GS, Fedorin MM, Fofanova TV, Shepel RN, Yagoda AV, Yakushin SS. Treatment management based on adherence: patient recommendation algorithms. Cross-disciplinary guidelines. Medical News of North Caucasus. 2020;15(4):461-468. (In Russ.). https://doi.org/10.14300/mnnc.2020.15109
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.